Zobrazeno 1 - 10
of 277
pro vyhledávání: '"C. J. L. M Meijer"'
Autor:
R. Donken, J. Hoes, M. J. Knol, G. S. Ogilvie, S. Dobson, A. J. King, J. Singer, P. J. Woestenberg, J. A. Bogaards, C. J. L. M. Meijer, H. E. de Melker
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Persistent high-risk human papillomavirus (HPV) infection is endorsed by the World Health Organization as an intermediate endpoint for evaluating HPV vaccine effectiveness/efficacy. There are different approaches to estimate the v
Externí odkaz:
https://doaj.org/article/1b50c14827be44628c3749ef654cffcd
Autor:
I. S. van Houdt, B. J. R. Sluijter, P. A. M. van Leeuwen, L. M. Moesbergen, E. Hooijberg, C. J. L. M. Meijer, T. D. de Gruijl, J. J. Oudejans, E. Boven
Publikováno v:
Cellular Oncology, Vol 31, Iss 5, Pp 407-413 (2009)
Background: Sentinel Lymph Node (SLN) status is strongly related to clinical outcome in melanoma patients. In this study we investigated the possible association between the presence of activated and/or suppressive Tumour Infiltrating Lymphocytes (TI
Externí odkaz:
https://doaj.org/article/0cdc6b2d8f9947d4948a133008067621
Autor:
D. Kramer, F. B. Thunnissen, M. I. Gallegos-Ruiz, E. F. Smit, P. E. Postmus, C. J. L. M. Meijer, P.J.F. Snijders, D. A. M. Heideman
Publikováno v:
Cellular Oncology, Vol 31, Iss 3, Pp 161-167 (2009)
Background: Increasing evidence points to a negative correlation between K-ras mutations and patient’s response to, or survival benefit after, treatment with EGFR-inhibitors. Therefore, rapid and reliable assays for mutational analysis of the K-ras
Externí odkaz:
https://doaj.org/article/b3dca800acbe4d7e9877d48b2e718323
Autor:
D. A. M. Heideman, F. B. Thunnissen, M. Doeleman, D. Kramer, H. M. Verheul, E. F. Smit, P. E. Postmus, C. J. L. M. Meijer, G.A. Meijer, P. J. F. Snijders
Publikováno v:
Cellular Oncology, Vol 31, Iss 5, Pp 329-333 (2009)
Background: Increasing data from clinical trials support EGFR and K-ras mutation status as predictive markers of tumour response to EGFR-targeted therapies. Consequently, rapid and reliable mutation screening assays are demanded to guide rational use
Externí odkaz:
https://doaj.org/article/0ea96d7979ce4bb1a0a7eaa416f018b2
Autor:
Donken, R., J. Hoes, M. J. Knol, G. S. Ogilvie, S. Dobson, A. J. King, J. Singer, P. J. Woestenberg, J. A. Bogaards, C. J. L. M. Meijer, H. E. De Melker
Additional file 2. Examples of calculations for different approaches with regard to number of events and person time at risk.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8414f2fc0e237d86d427497d039d4c48
Autor:
Donken, R., J. Hoes, M. J. Knol, G. S. Ogilvie, S. Dobson, A. J. King, J. Singer, P. J. Woestenberg, J. A. Bogaards, C. J. L. M. Meijer, H. E. De Melker
Additional file 1. Search query
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c46ba09cc66781e3975488dafc165c
Autor:
Birgit I. Lissenberg-Witte, Renske D.M. Steenbergen, Daniëlle A M Heideman, Albert G. Siebers, Mcg Bleeker, Frederique J Vink, J. Berkhof, F. J. van Kemenade, C. J. L. M. Meijer
Publikováno v:
Clinical Microbiological and Infection, 27(1), 125.e1-125.e6
Clinical Microbiology and Infection, 27(1), 125.e1-125.e6. Elsevier Ltd.
Vink, F J, Lissenberg-Witte, B I, Meijer, C J L M, Berkhof, J, van Kemenade, F J, Siebers, A G, Steenbergen, R D M, Bleeker, M C G & Heideman, D A M 2021, ' FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women : cross-sectional and longitudinal data from a Dutch screening cohort ', Clinical Microbiological and Infection, vol. 27, no. 1, pp. 125.e1-125.e6 . https://doi.org/10.1016/j.cmi.2020.03.018
Clinical Microbiology and Infection, 27(1), 125.e1-125.e6. Elsevier Ltd.
Vink, F J, Lissenberg-Witte, B I, Meijer, C J L M, Berkhof, J, van Kemenade, F J, Siebers, A G, Steenbergen, R D M, Bleeker, M C G & Heideman, D A M 2021, ' FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women : cross-sectional and longitudinal data from a Dutch screening cohort ', Clinical Microbiological and Infection, vol. 27, no. 1, pp. 125.e1-125.e6 . https://doi.org/10.1016/j.cmi.2020.03.018
OBJECTIVES: The aim was to evaluate the cross-sectional and long-term triage performance of FAM19A4/miR124-2 methylation analysis in human papillomavirus (HPV)-based cervical screening.METHODS: We conducted a post hoc analysis within a Dutch populati
Publikováno v:
Polman, N J, Snijders, P J F, Kenter, G G, Berkhof, J & Meijer, C J L M 2019, ' HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme ', Preventive Medicine, vol. 119, pp. 108-117 . https://doi.org/10.1016/j.ypmed.2018.12.021
Based on scientific data showing that HPV testing provides better protection against cervical precancer and cancer than cytology, in 2011 the Dutch Health Council advised the Minister of Welfare, Health and Sports to replace cytology by HPV testing i
It was Lee1 who was the first to use an estrogen-bovine serum albumin fluorescein isothiocyanate (O-BSA-FITC) complex in order to demonstrate estrogen binding sites in thin sections of mammary tumors. Synthesis of this O-BSA-FITC complex is relativel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c5dadcf0bebd134eedbf1de74b685ae
https://doi.org/10.1201/9781351074155
https://doi.org/10.1201/9781351074155
Autor:
P. J. F. Snijders, D.A.M. Heideman, F. Topal, Johannes Berkhof, Albertus T. Hesselink, C. J. L. M. Meijer, René Pol
Publikováno v:
Hesselink, A T, Heideman, D A M, Berkhof, J, Topal, F, Pol, R P, Meijer, C J L M & Snijders, P J F 2010, ' Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening ', Journal of Clinical Microbiology, vol. 48, no. 3, pp. 797-801 . https://doi.org/10.1128/JCM.01743-09
Journal of Clinical Microbiology, 48(3), 797-801. American Society for Microbiology
Journal of Clinical Microbiology, 48(3), 797-801. American Society for Microbiology
We compared the clinical performance of the PapilloCheck human papillomavirus (HPV) assay with that of the GP5+/6+-PCR method with an enzyme immunoassay readout (GP5+/6+-PCR-EIA) for the detection of high-risk HPV (hrHPV) types by the use of cervical